|
New Delhi, Feb 12: Even as India makes its mark in the world with its vaccine diplomacy amid the Covid crisis, there are few international takers for its homemade vaccine Covaxin.
Covaxin is yet to complete its phase III trials is evidently a sore point. Bharat Biotech had started phase III trials for Covaxin in November 2020, enrolling 25,800 volunteers across India.
India’s first indigenous vaccine against Covid-19 was to be sent pro bono to Myanmar, Mongolia, Oman, Bahrain, the Philipines, Maldives and Mauritius as a goodwill gesture.
The decision was taken at a high-level meeting on January 18, at the health ministry between the Union Health Minister Harsh Vardhan, Minister of External…
